Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Dropping the price

<< Previous

Bullboard Posts

Next >>

Comment by whisky11on Apr 23, 2021 1:16pm

127 Views

Post# 33055857

RE:Dropping the price

Mick00333]People are dropping the price, but what gonna happen when the price will reach 0.01 ?? they will cry because it cant goes up or the compagnie will bankcrup and everyone going to lose everything...

whisky11: you worry too much, you sound miserable.
It won't go to 0.01 but your IQ will. So what was the reason for posting something idiotic like this ?
Well I would have probably answer; your stupid like a shoe or you want to buy cheap shares.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market